Nasdaq-listed Newgenivf disclosed its 2025 trading activity in SOL, BTC, ETH and XRP, including the full sale of 146,432 XRP purchased during the year for a realized gain of about $10,800. The company also bought and sold small amounts of BTC and ETH during the same period. It retained about 13,000 SOL at year-end, carrying an unrealized loss of approximately $1.28 million.